- Design
- Multicentre, single-blind, randomised superiority trial
- Population
- 1,111 high-risk patients having elective major abdominal surgery
- Primary outcome
- Composite of AKI, myocardial injury, severe infection, cardiac arrest or death at 7 days
- Effect
- 44.3% vs 46.9%; RR 0.94 (95.1% CI 0.83–1.08)
PELICAN, in JAMA, randomised 1,111 high-risk patients having elective major abdominal surgery at 12 European university centres. One group received haemodynamic therapy aimed at keeping cardiac index at the patient's own preoperative resting value; the other received routine care with cardiac index monitored but hidden.
The composite of acute kidney injury, myocardial injury, severe infection, non-fatal cardiac arrest or death within seven days occurred in 44.3% versus 46.9% (RR 0.94). No individual component differed.
Individualised flow targets are an appealing idea and have been widely promoted. This trial suggests that, in high-risk abdominal surgery, steering to a personal cardiac index does not reduce early complications compared with good routine care.
Anaesthetic teams need not add cardiac output-guided targets to routine practice on the basis of this idea; standard haemodynamic management remains appropriate.
- Do not adopt personal cardiac index targets for major abdominal surgery on current evidence
- Expect early complications in nearly half of high-risk major abdominal surgery patients
- Use the high complication rate when consenting high-risk patients
Why it matters
Individualised flow targets have been promoted without trial proof, and this trial did not provide it.
The statistics, in plain English
An RR of 0.94 with an interval from 0.83 to 1.08 means anything from a 17% reduction to an 8% increase fits the data, so a large benefit is unlikely.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for top clinical updates, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free